Quarterly report pursuant to Section 13 or 15(d)

Note 7 - Earnings Per Share

v3.21.2
Note 7 - Earnings Per Share
9 Months Ended
Sep. 30, 2021
Notes to Financial Statements  
Earnings Per Share [Text Block]

Note 7 - EARNINGS PER SHARE

 

The following table sets forth the computation of basic and diluted earnings per share (in thousands, except share data) :

 

   

For the Nine Months

Ended September 30,

   

For the Three Months

Ended September 30,

 
   

2021

   

2020

   

2021

   

2020

 

Numerator:

                               

Net Income (Loss)

  $ 7,133     $ (13,452 )   $ 2,779     $ (14,454 )

Less: Preferred Stock Dividends

    (4 )     (12 )     -       (4 )

Less: Net Income Attributable to OP Interest

    (178 )     (102 )     (64 )     (102 )

Less: Net Income Attributable to Restricted Stock Units

    (58 )     -       (18 )     -  

Net Income (Loss) Attributable to Common Stockholders

  $ 6,893     $ (13,566 )   $ 2,697     $ (14,560 )
                                 

Denominator:

                               

Weighted Average Shares of Common Stock Outstanding - Basic

    15,588,544       7,103,706       19,410,307       7,188,015  

Dilutive Effect of Options and Warrants

    48,520       -       145,560       -  

Weighted Average Shares of Common Stock Outstanding - Diluted

    15,637,064       7,103,706       19,555,867       7,188,015  
                                 

Earnings Per Share - Basic

                               

Net Income (Loss) Attributable to Common Stockholders

  $ 0.44     $ (1.91 )   $ 0.14     $ (2.03 )

Earnings Per Share - Diluted

                               

Net Income (Loss) Attributable to Common Stockholders

  $ 0.44     $ (1.91 )   $ 0.14     $ (2.03 )

 

The effect of including 791,790 outstanding stock options and 602,392 warrants were excluded from our calculation of weighted average shares of common stock outstanding – diluted for the nine months ended September 30, 2020 and the three months ended September 30, 2020 as their inclusion would have been anti-dilutive. The effect of including 791,790 outstanding stock options and 602,392 warrants were included in our calculation of weighted average shares of common stock outstanding – diluted for the nine months ended September 30, 2021 and the three months ended September 30, 2021. The effect of including 127,176 RSUs and 453,303 OP Units were excluded from our calculation of weighted average shares of common stock outstanding – diluted for all periods presented as their inclusion would have been anti-dilutive.